AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Net Margin Over TimeStable
Percentile Rank29
3Y CAGR-0.9%
5Y CAGR-2.3%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
-0.9%/yr
vs -6.4%/yr prior
5Y CAGR
-2.3%/yr
Consistent
Acceleration
+5.5pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
202510.99%+0.4%
202410.94%+41.1%
20237.75%-31.3%
202211.29%-47.6%
202121.53%+74.8%
202012.32%+1.9%
201912.09%-17.9%
201814.72%-4.5%
201715.41%+5.2%
201614.66%-